Tokyo-listed accounting software provider Freee is set to raise up to JPY42.5 billion ($391 million) through an offering of new shares and the sale of shares held by DCM Ventures.
Overseas investors will be offered 4.6 million new shares, while 481,800 existing shares will be sold. The company's stock fell 11% following the announcement to as low as JPY9,090 before closing on March...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.
Northleaf Capital Partners, a Canada-based asset manager that invests in private equity, private credit, and infrastructure, has opened a Tokyo office to spearhead fundraising activity in Asia and is considering the addition of a Korea presence.